RBC Capital raised the firm’s price target on Waystar to $31 from $27 and keeps an Outperform rating on the shares. The firm is adjusting its estimates after holding talks with the management about the composition and durability of the drivers of the Q2 revenue outperformance – notably the impact of the Change Healthcare outage, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WAY: